L
2.40
0.00 (0.00%)
| Previous Close | 2.40 |
| Open | 2.49 |
| Volume | 24,795 |
| Avg. Volume (3M) | 36,855 |
| Market Cap | 18,000,000 |
| Price / Sales | 1.05 |
| Price / Book | 5.31 |
| 52 Weeks Range |
| Profit Margin | -1.23% |
| Operating Margin (TTM) | -6.58% |
| Diluted EPS (TTM) | -0.170 |
| Quarterly Revenue Growth (YOY) | 17.00% |
| Quarterly Earnings Growth (YOY) | -99.60% |
| Total Debt/Equity (MRQ) | 723.93% |
| Current Ratio (MRQ) | 0.600 |
| Levered Free Cash Flow (TTM) | 1.22 M |
| Return on Assets (TTM) | -3.86% |
| Return on Equity (TTM) | -30.55% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Integrated Freight & Logistics (US) | Bullish | Bearish |
| Integrated Freight & Logistics (Global) | Mixed | Bearish | |
| Stock | Lakeside Holding Limited | - | - |
AIStockmoo Score
0.8
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | 0.75 |
|
Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services. |
|
| Sector | Industrials |
| Industry | Integrated Freight & Logistics |
| Investment Style | Small Core |
| % Held by Insiders | 76.01% |
| % Held by Institutions | 0.19% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 17 Dec 2024 | Announcement | Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary |
| 03 Dec 2024 | Announcement | Lakeside Holding to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference |
| 25 Nov 2024 | Announcement | Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts |
| 15 Nov 2024 | Announcement | LAKESIDE HOLDING PROVIDES FIRST QUARTER OF FISCAL YEAR 2025 RESULTS |
| 11 Nov 2024 | Announcement | Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd. |
| 01 Oct 2024 | Announcement | Lakeside Holding Reports Impressive 42% Revenue Growth for Fiscal Year 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |